IBIO vs. PFE
IBIO (iBio, Inc.) and PFE (Pfizer Inc.) are both stocks. Both are in the Healthcare sector — IBIO in Biotechnology, PFE in Drug Manufacturers - General. Over the past 10 years, IBIO returned -52.72%/yr vs 1.85%/yr for PFE. At a 0.06 correlation, their price movements are largely independent.
Performance
IBIO vs. PFE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IBIO achieves a -4.66% return, which is significantly lower than PFE's 5.18% return. Over the past 10 years, IBIO has underperformed PFE with an annualized return of -52.72%, while PFE has yielded a comparatively higher 1.85% annualized return.
IBIO
- 1D
- 4.55%
- 1M
- 16.46%
- YTD
- -4.66%
- 6M
- 76.92%
- 1Y
- 118.55%
- 3Y*
- -50.27%
- 5Y*
- -69.52%
- 10Y*
- -52.72%
PFE
- 1D
- -0.82%
- 1M
- -2.06%
- YTD
- 5.18%
- 6M
- 2.42%
- 1Y
- 16.11%
- 3Y*
- -7.32%
- 5Y*
- -3.51%
- 10Y*
- 1.85%
IBIO vs. PFE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
IBIO iBio, Inc. | -4.66% | -21.22% | 78.83% | -84.59% | -96.76% | -47.71% | 320.00% | -66.82% | -58.14% | -54.43% |
PFE Pfizer Inc. | 5.18% | 0.65% | -2.22% | -41.26% | -10.41% | 66.70% | 3.07% | -6.91% | 24.82% | 15.90% |
Correlation
The correlation between IBIO and PFE is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.10 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.07 |
Correlation (All Time) Calculated using the full available price history since Aug 14, 2012 | 0.06 |
The correlation between IBIO and PFE shifts across timeframes, from 0.06 (all time) to 0.17 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
IBIO:
$220.06M
PFE:
$145.22B
IBIO:
-$0.38
PFE:
$1.31
IBIO:
441.81
PFE:
2.28
IBIO:
2.84
PFE:
1.61
IBIO:
$300.00K
PFE:
$63.32B
IBIO:
-$230.00K
PFE:
$43.91B
IBIO:
-$16.93M
PFE:
$16.94B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IBIO vs. PFE — Risk / Return Rank
IBIO
PFE
IBIO vs. PFE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iBio, Inc. (IBIO) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IBIO | PFE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.33 | ||
| Sortino ratioReturn per unit of downside risk | +1.07 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.14 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | 2.22 | 1.41 | +0.81 |
| Martin ratioReturn relative to average drawdown | 4.22 | 2.91 | +1.31 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IBIO | PFE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.01 | 0.68 | +0.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.45 | -0.14 | -0.32 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.34 | 0.08 | -0.41 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.23 | 0.23 | -0.46 |
Drawdowns
IBIO vs. PFE - Drawdown Comparison
The maximum IBIO drawdown since its inception was -100.00%, which is greater than PFE's maximum drawdown of -58.96%. Use the drawdown chart below to compare losses from any high point for IBIO and PFE.
Loading charts...
Drawdown Indicators
| IBIO | PFE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -58.96% | -41.04% |
Max Drawdown (1Y)Largest decline over 1 year | -53.75% | -11.47% | -42.28% |
Max Drawdown (3Y)Largest decline over 3 years | -96.51% | -40.75% | -55.76% |
Max Drawdown (5Y)Largest decline over 5 years | -99.93% | -58.96% | -40.97% |
Max Drawdown (10Y)Largest decline over 10 years | -99.98% | -58.96% | -41.02% |
Current DrawdownCurrent decline from peak | -99.99% | -47.49% | -52.50% |
Average DrawdownAverage peak-to-trough decline | -86.67% | -17.68% | -68.99% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.20% | 5.54% | +22.66% |
Volatility
IBIO vs. PFE - Volatility Comparison
iBio, Inc. (IBIO) has a higher volatility of 25.85% compared to Pfizer Inc. (PFE) at 4.07%. This indicates that IBIO's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IBIO | PFE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 25.85% | 4.07% | +21.78% |
Volatility (6M)Calculated over the trailing 6-month period | 87.93% | 14.64% | +73.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 117.92% | 23.85% | +94.07% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 153.40% | 25.49% | +127.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 156.98% | 23.88% | +133.10% |
Dividends
IBIO vs. PFE - Dividend Comparison
IBIO has not paid dividends to shareholders, while PFE's dividend yield for the trailing twelve months is around 6.79%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IBIO iBio, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PFE Pfizer Inc. | 6.79% | 6.91% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.53% | 3.69% | 3.47% |
Financials
IBIO vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between iBio, Inc. and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
IBIO and PFE have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IBIO has higher volatility (25.85%) compared to PFE (4.07%). In terms of maximum drawdown, IBIO dropped -100.00% vs PFE's -58.96%.
IBIO currently has the higher Sharpe Ratio (1.01 vs 0.68), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IBIO and PFE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer